Zobrazeno 1 - 10
of 185
pro vyhledávání: '"Irene Gavras"'
Autor:
Talma Rosenthal, Irene Gavras
Publikováno v:
Anticancer Research. 39:4597-4602
Our previous review of the literature assessed the existing knowledge (until 2000) about the possible link between angiotensin-converting enzyme inhibitors (ACEIs) and factors influencing the development of malignancies. We reviewed the literature fo
Publikováno v:
Current Vascular Pharmacology. 12:4-15
From the first description of its anatomy by T. Willis to the novel therapeutic manipulations, it is unanimously recognized that the sympathetic nervous system (SNS) holds a crucial role in cardiovascular homeostasis. The introduction of sophisticate
Autor:
S. Maragkoudakis, Panagiotis Vardas, Haralambos Gavras, Irene Gavras, Joanna E. Kontaraki, Fragiskos I. Parthenakis, M. Marketou, Evangelos A. Zacharis
Publikováno v:
Journal of Human Hypertension. 28:450-455
Bradykinin participates in various hypertensive processes, exerted via its type 1 and type 2 receptors (BKR1 and BKR2). The aim of the study was to investigate BKR1 and BK2R gene expression in peripheral monocytes in patients with essential hypertens
Autor:
Irene Gavras, Haralambos Gavras
Publikováno v:
Journal of Hypertension. 30:655-659
It is widely believed that salt-dependent hypertension is induced and maintained by expansion of intravascular fluid volume resulting from excessive retention of sodium. The purpose of this brief article is to present a series of arguments in support
Autor:
D. Vougia, Maria E. Marketou, Joanna E. Kontaraki, J. Konstantinou, Irene Gavras, P. Tsiverdis, J. Logakis, Panos E. Vardas, A. Spanaki, Haralambos Gavras, Frangiskos I. Parthenakis
Publikováno v:
Journal of Hypertension. 35:e333-e334
Publikováno v:
Hypertension Research. 33:772-777
Following the introduction of angiotensin-converting enzyme (ACE) inhibitors in the treatment of hypertension and ischemic heart disease, there has been increasing interest in the bradykinin-mediated aspects of ACE inhibition. Several preclinical and
Autor:
Talma Rosenthal, Irene Gavras
Publikováno v:
Journal of Human Hypertension. 23:623-635
After an early report that patients treated with angiotensin-converting enzyme (ACE) inhibitors had a lower than expected incidence of cancers, there was a large number of publications investigating the possible pathophysiological mechanism mediating
Autor:
Teresa A. Hopkins, Irena Duka, Arvi Duka, Irene Gavras, Michael Bader, Ekaterina Kintsurashvili, Haralambos Gavras, Deborah Ona
Publikováno v:
Hypertension. 51:1352-1357
We sought to define the contribution of each of the 2 kinin receptors (bradykinin 1 receptor [B 1 R] and bradykinin 2 receptor [B 2 R]) to the cardioprotection of angiotensin-converting enzyme (ACE) inhibition after acute myocardial infarct. Wild-typ
Autor:
Sherene M, Shenouda, Conrado, Johns, Ekaterina, Kintsurashvili, Irene, Gavras, Haralambos, Gavras
Publikováno v:
American Journal of Hypertension. 19:1135-1143
Background Salt-induced hypertension is mediated via the α 2B -adrenergic receptor (AR) subtype. In α 2B -AR gene knockout mice, blood pressure (BP) does not rise with salt loading, and in rats with salt-induced hypertension, BP decreases transient
Publikováno v:
American Journal of Physiology-Endocrinology and Metabolism. 291:E268-E274
With inhibition or absence of the bradykinin B2 receptor (B2R), B1R is upregulated and assumes some of the hemodynamic properties of B2R, indicating that both participate in the maintenance of normal vasoregulation or to development of hypertension.